Stride Pharma has been taking strong support around 756 - 757. The 200-day ema is placed at 754, the stock may bounce from this level and is possibly a good buy with a favourable risk-reward.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.